Skip to content

Haut-Tief Patient Education on Psoriasis and Eczema

A Prospective, Randomized, Controlled Study of the Impact of Education and Stress-reduction Techniques on Psoriasis and Eczema.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02205593
Enrollment
80
Registered
2014-07-31
Start date
2012-07-31
Completion date
2022-12-31
Last updated
2019-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis/ Eczema, Psoriasis

Keywords

psoriasis, atopic dermatitis, eczema, patient education, stress reduction, quality of life

Brief summary

'Haut-Tief' (Skin Deep) is an educational, stress reducing program for patients with psoriasis or atopic dermatitis. A range of support activities will be offered in order to learn effective self-management strategies and attitude to one's chronic skin disease and consequently improving quality of life.

Detailed description

The educational program consists of 2-hours of educational (dermatology, specialized nurse, psychologist) and stress-reduction sessions (yoga, meditation, physiotherapy) twice a week during 9 weeks. A multidisciplinary team of trainers is involved. Primary endpoint is the general and skin dependent quality of life measured by questionnaires. HRQoL (Health-Related Quality of Life) is measured at baseline, after 3 months, 6 months and 9 months follow up. Patients are recruited from the out-patient clinic at the Department of Dermatology of the University Hospital Zurich. Patients are randomized in an intervention and control group. Intervention group receives the education program additionally to follow-up visits whereas the control group receives follow-up visits. Several runs are planned.

Interventions

BEHAVIORALControl

Regular follow-up and treatment WITHOUT behavioural intervention

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Chronic psoriasis (disease for more than 3 months) * Chronic eczema (disease for more than 3) months) * Age ≥ 18 years * Oral and written informed consent

Exclusion criteria

* systemic antiinflammatory therapy * treatment with other investigational products * other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc), * known or suspected non-compliance, drug or alcohol abuse, * inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia or confusional state of the subject * participation in another study within the 30 days preceding and during the present study, (viii) previous enrollment into the current study, * enrolment of the investigator, his/her family members, employees and other dependent persons.

Design outcomes

Primary

MeasureTime frameDescription
change in ShortForm 36 score [ ]baseline, 3 months, 6 months, 9 monthsQuestionnaire measuring Health related quality of life
change in EQ VAS (EQ visual analogue scale) score [ ]baseline, 3 months, 6 months, 9 monthsQuestionnaire measuring Health related quality of life
change in DLQI (Dermatology Life Quality Index) score [ ]baseline, 3 months, 6 months, 9 monthsDLQI is a questionnaire measuring Health related quality of life 10 questions
change in Skindex-29 score [ ]baseline, 3 months, 6 months, 9 monthsQuestionnaire measuring Health related quality of life 29 questions
change in EQ 5D score [ ]baseline, 3 months, 6 months, 9 monthsQuestionnaire measuring Health related quality of life

Secondary

MeasureTime frameDescription
change in PASI (psoriasis area and severity index) [ ]baseline, 3 months, 6 months, 9 monthsclinical score for psoriasis
BDI (Beck Depression Inventory) score [ ]baseline, 3 months, 6 months, 9 months
change in EASI (eczema area and severity index) score [ ]baseline, 3 months, 6 months, 9 monthsclinical score for atopic dermatitis

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026